RUNX1-RUNX1T1 Fusion Protein Expression
1 clinical trials · Condition
◉ Watch RUNX1-RUNX1T1 Fusion Protein Expression
| Record | Firm | Date |
|---|---|---|
| Standard-dose vs Intermediate-dose Cytarabine Induction in the Treatment of Acute Myeloid Leukemia With RUNX1-RUNX1T1 (NCT06744504) | Institute of Hematology & Blood Diseases Hospital, China | 2025-01-10 |
Track RUNX1-RUNX1T1 Fusion Protein Expression automatically
Every clearance here is in the API, with alerts when new ones post.